Skip to Main Content

Paper Details

Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis.
Kidney Int
18
2023
FSGS, Kidney organoids, MCD, MCP-1, TIMP-1, TNF, focal segmental glomerulosclerosis, kidney cells, minimal change disease, monocyte chemoattractant protein-1, nephrotic syndrome, patient, patients, resident, tissue inhibitor of metalloproteinases-1, tumor, tumor necrosis factor
Author NameAffiliation
Laura H MarianiUniversity of Michigan ann arbor
Sean EddyUniversity of Michigan ann arbor
Viji NairUniversity of Michigan ann arbor
Felix EichingerUniversity of Michigan ann arbor
Felix EichingerUniversity of Michigan ann arbor
Heather N ReichUniversity Health Network and University of Toronto
Bradley GodfreyUniversity of Michigan ann arbor
Wenjun JuUniversity of Michigan ann arbor
Sharon G AdlerDivision of Nephrology and Hypertension at Harbor-university of california los angeles Medical Center and The Lundquist Institute for Biomedical Innovation
Laura BarisoniDuke University School of Medicine
Vimal K DerebailUniversity of North Carolina Kidney Center, University of North Carolina at Chapel Hill
Jeffrey B HodginUniversity of Michigan ann arbor
Jeffrey B HodginUniversity of Michigan ann arbor
Jeffrey B KoppNational Institute of Diabetes and Digestive Diseases, National Institutes of Health
John C LieskeMayo Clinic
Cheryl L TranMayo Clinic
Debbie S GipsonUniversity of Michigan ann arbor
Matthias KretzlerUniversity of Michigan ann arbor
Matthias KretzlerUniversity of Michigan ann arbor
  • 1 - 19

Datasets

Release 1.2